SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001180469-05-000008
Filing Date
2005-06-02
Accepted
2005-06-02 11:51:38
Documents
1
Period of Report
2000-12-21

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4/A  
1 PRIMARY DOCUMENT edgar.xml 4/A 8692
  Complete submission text file 0001180469-05-000008.txt   10542
Mailing Address 3151 SOUTH 17TH ST WILMINGTON NC 28412
Business Address 3151 SOUTH 17TH ST WILMINGTON NC 28412 9102510081
PHARMACEUTICAL PRODUCT DEVELOPMENT INC (Issuer) CIK: 0001003124 (see all company filings)

IRS No.: 561640186 | State of Incorp.: NC | Fiscal Year End: 1231
SIC: 8731 Services-Commercial Physical & Biological Research

Mailing Address RELIANT PHARMACEUTICALS, LLC 110 ALLEN ROAD LIBERTY CORNER NJ 07938
Business Address (908)580-1200
MARIO ERNEST (Reporting) CIK: 0001180469 (see all company filings)

Type: 4/A | Act: 34 | File No.: 000-27570 | Film No.: 05872724